Tirzepatide is a novel dual agonist targeting both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. This pharmaceutical-grade compound demonstrates significant potential for metabolic research, particularly in studies related to type 2 diabetes and weight management.
The mechanism of action involves simultaneous activation of both incretin hormone pathways, resulting in enhanced glucose control, delayed gastric emptying, and appetite suppression. These properties make Tirzepatide an important compound for metabolic research applications.
Our facility produces Tirzepatide to the highest purity standards (99%), ensuring reliable results for research purposes. The competitive tirzepatide UK price makes this compound accessible for various research applications while maintaining strict quality control.
As a manufacturer, we specialize in bulk supply and custom synthesis of Tirzepatide to meet specific research requirements. The compound is provided exclusively for laboratory research purposes and is not intended for human consumption.